HKSE - Delayed Quote HKD
CSPC PHARMA (1093.HK)
5.730
-0.110
(-1.88%)
At close: 4:08:23 PM GMT+8
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 3.57B | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.78 per share. | Direct | 3,523,950 | Apr 25, 2025 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.78 per share. | Direct | 4,525,162 | Apr 24, 2025 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.60 per share. | Direct | 604,300 | Apr 9, 2025 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.62 per share. | Direct | 4,097,730 | Apr 8, 2025 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.62 per share. | Direct | 4,126,530 | Apr 7, 2025 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.62 per share. | Direct | 617,000 | Dec 13, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.65 per share. | Direct | 314,938 | Nov 27, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.65 per share. | Direct | 261,080 | Nov 26, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.65 per share. | Direct | 653,000 | Nov 25, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.66 per share. | Direct | 661,600 | Nov 22, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.67 per share. | Direct | 133,880 | Nov 21, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.66 per share. | Direct | 263,360 | Nov 19, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.59 per share. | Direct | 591,500 | Sep 9, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.62 per share. | Direct | 616,700 | Aug 29, 2024 |
Jiang (Hao) Director (Executive) | Acquisition at price 0.61 per share. | Direct | 121,820 | Aug 29, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.61 per share. | Direct | 1,031,900 | Aug 28, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.61 per share. | Direct | 490,880 | Aug 26, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.61 per share. | Direct | 730,080 | Aug 23, 2024 |
Cai (Dong Chen) Chairman of the Board | Acquisition at price 0.63 per share. | Direct | 862,214 | Aug 22, 2024 |
Zhang (Cuilong) Chief Executive Officer | Acquisition at price 0.63 per share. | Direct | 627,500 | Aug 22, 2024 |
Cai (Dong Chen) Chairman of the Board | Conversion at price 0.76 per share. | Direct | 6,866,100 | Apr 11, 2024 |
Chak (Kin Man) Director (Executive) | Conversion at price 0.76 per share. | Direct | 228,870 | Apr 11, 2024 |
Jiang (Hao) Director (Executive) | Conversion at price 0.76 per share. | Direct | 152,580 | Apr 11, 2024 |
Li (Chunlei) Director (Executive) | Conversion at price 0.76 per share. | Direct | 1,144,350 | Apr 11, 2024 |
Pan (Weidong) Director (Executive) | Conversion at price 0.76 per share. | Direct | 1,144,350 | Apr 11, 2024 |
Wang (Huaiyu) Director (Executive) | Conversion at price 0.76 per share. | Direct | 1,144,350 | Apr 11, 2024 |
Wang (Zhenguo) Director (Executive) | Conversion at price 0.76 per share. | Direct | 1,144,350 | Apr 11, 2024 |
Zhang (Cuilong) Chief Executive Officer | Conversion at price 0.76 per share. | Direct | 3,051,600 | Apr 11, 2024 |
Related Tickers
000908.SZ Hunan Jingfeng Pharmaceutical Co.,Ltd.
4.7900
-4.39%
0Q1N.IL Pfizer Inc.
24.08
0.00%
1643.HK MODERN CHI MED
0.330
-1.49%
4519.T Chugai Pharmaceutical Co., Ltd.
8,470.00
-1.74%
H02.SI Haw Par Corporation Limited
11.50
-0.95%
SAN.PA Sanofi
91.67
-4.31%
BIIB Biogen Inc.
117.21
+0.33%
AZN.L AstraZeneca PLC
10,504.00
-1.83%
NONOF Novo Nordisk A/S
66.20
-1.93%
ROG.SW Roche Holding AG
266.20
-1.92%